Navigation Links
Rapid in Medical Technology
NEW YORK, June 25 /PRNewswire-USNewswire/ -- As of mid-2009, The Michael J. Fox Foundation for Parkinson's Research has already funded over $1 million in high-risk, high-reward approaches to Parkinson's therapeutic development through its groundbreaking Rapid Response Innovation Awards . Projects...
- Significant peak urine flow (Qmax) improvements within 2-6 hours of the first dose, according to published data - CORONA, Calif., May 8 /PRNewswire-FirstCall/ -- RAPAFLO (TM) (silodosin), a new, uniquely selective alpha blocker for the treatment of the signs and symptoms of BPH, produ...
Tasigna now shows potential to become the treatment of choice for certain newly diagnosed patients with chronic myeloid leukemia Two separate studies show rapid elimination of cancer cells in 96% of Tasigna patients and reduction of abnormal CML protein by six months ...
CIMZIA(R) Data Shows Long-term Improvements in Productivity, Quality of Life and Lessened Fatigue According to Studies Presented at American College of Rheumatology (ACR) Annual Scientific Meeting SAN FRANCISCO, Oct. 27 /PRNewswire/ -- 5:00 AM PST -- UCB announced today results from se...
$2 million in total funding expected by year's end NEW YORK, July 29 /PRNewswire-USNewswire/ -- Gene silencing techniques and induced pluripotent stem cell technology are among the cutting-edge approaches to Parkinson's drug development funded through The Michael J. Fox Foundation's Rapid Re...
SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM ) and its operating unit InnerCool Therapies announced today that positive findings from a preclinical study, demonstrating a new and expanded benefit of early rapid hyperthermia (cooling) for the potential treatmen...
ZFN Technology has Broad Applications in Research, Drug Development and Therapeutics ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL ) and Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the pub...
CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported data for IDX899, a non-nucleoside rever...
Marked Improvement in Four Regions of Body Consistent with Overall PASI Response in REMICADE-Treated Patients SAN ANTONIO, Feb. 4 /PRNewswire/ -- Data from an integrated analysis of three randomized, placebo-controlled trials showed patients with moderate to severe plaque psori...
- 85% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg and Pegasys(R) plus Copegus(R) with safety and tolerability comparable to placebo - - Conference Call Scheduled for 4:00PM ET Today - PRINCETON, N.J., Jan. 7 /PRNew...
Tests for Skin and Soft Tissue Infection and Blood Culture Extend European Product Line for Healthcare Acquired Infections SUNNYVALE, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the European release of Xpert(TM) MRSA/SA-Blood Cultures (BC) and Xper...
SAN FRANCISCO, Oct. 16 /PRNewswire/ -- Sugammadex -- the novel selective relaxant binding agent (SRBA) being developed by Organon -- demonstrated a faster recovery from profound neuromuscular blockade as compared to neostigmine in the Phase III pivotal Signal trial.(1) In a second trial, named...
Symptom resolution results based on stringent endpoint of clinical remission is more clinically relevant, beneficial to patients PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- An analysis of data to be presented tomorrow at the American College of Gastroenterology (ACG) Annual Scientif...
SUNNYVALE, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the termination of its contract with the Centers for Disease Control and Prevention (CDC) for development of a rapid point-of-care diagnostic to detect influenza viruses A and B, and the H5N1 "Avian In...
CHICAGO, Sept. 19 /PRNewswire/ -- Targanta Therapeutics Corporation today released detailed data from completed studies comparing the in vitro activity of its lead antibiotic drug candidate, oritavancin, to that of other antibiotics against a variety of susceptible and resistant strains of gra...
DALLAS, Sept. 12 /PRNewswire/ -- With equal access to medical care and medication, Hispanic men and women have as good or greater chance as non- Hispanics of controlling their high blood pressure. When researchers studied blood pressure control in Hispanics as part of the ALLHAT (Antihypertens...
First Molecular Test to Simultaneously Identify Staphylococcus Aureus and Methicillin-Resistant Staphylococcus Aureus from Nasal Specimens SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), announced today that it has ...
... O'Dea, MD, Chief Medical Officer of Radius. "The greater and faster accrual of BMD with BA058 may allow for shorter durations of treatment and a more rapid reduction in fracture risk in the severe osteoporotic postmenopausal population, which would be a significant advance in the treatment of this debilit...
... non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP((R)), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trade...
...reast cancer," says Dr. O'Shaughnessy. "We expect that accrual will be very rapid within the US Oncology network and hope that this trial will lead to rapid FDA approval of what appears so far to be a well tolerated and effective th...
...linical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer. The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and BENLYSTA(TM) (belimumab, formerl...
...day announced that Dr. Alan Epstein of the USC Keck School of Medicine has received approval for a $3.5 million drug development project through the rapid Access to Intervention Development (RAID) program of the National Cancer Institute (NCI) for his breakthrough Interleukin-2 (IL-2) cytokine immunother...
...cience Center at Fort Worth have determined that rapid estrogen administration can protect the brain foll... these animal studies of the protective effects of rapid estrogen treatment to human patients with severe t.... "Our animal research has demonstrated that rapid estrogen intervention protects the brain following...
...ting properties of this novel long-acting anticoagulant." Svein Mathisen, CEO of BioInvent, also commented, "We are pleased that there has been rapid progress in this study and that the efficacy and safety monitoring board unanimously recommended that we proceed to a higher dose of TB-402. It is tes...
...ulting from eastbound travel. Jet lag disorder is an acute condition that occurs when a person's internal body clock becomes disrupted as a result of rapid travel across several time zones. Based on U.S. Bureau of Labor Statistics findings, an estimated 70 million American travelers experience jet lag an...
... Phil., Sangamo's vice president of research. "Moreover, the efficiency of this approach obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ability to quickly and selectively knock out multiple genes in the...
...arbazepine Acetate Eslicarbazepine acetate (ESL) is a novel once-daily voltage-gated sodium channel blocker designed to selectively inhibit the rapid firing of nerve cells that causes seizures. It specifically targets the inactivated state of the ion channel, preventing its return to the active stat...
...monitoring. Through innovative wireless sensor technologies that use smartphones and broadband communication, we have the new capability of early and rapid detection of key parameters with a simple disposable smart 'band aid' that can relay the data on a continuous basis through the Internet." Parti...
...es company that commercializes breakthrough technologies for the molecular, rapid diagnostic testing market. The company is dedicated to development of simpl...improve automation, throughput, scalability, reliability and ease of use of rapid diagnostic testing for point-of-care settings such as physician's office la...
- Significant peak urine flow (Qmax) improvements within 2-6 hours of the first dose, according to published data - CORONA, Calif., May 8 /PRNewswire-FirstCall/ -- RAPAFLO (TM) (silodosin), a new, uniquely selective alpha blocker for the treatment of the signs and symptoms of BPH, produ...
Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip
SUNNYVALE, Calif., April 30 /PRNewswire-FirstCall/ -- Arrayit Corporation (OTC Bulletin Board: ARYC), a leading manufacturer of products and services for disease prevention, treatment and cure, announced today that it is developing a microarray-based diagnostic test to detect the H1N1 swine...CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
SUNNYVALE, Calif., March 2 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today significant growth in CyberKnife lung cancer treatments in calendar year 2008. The number of lung cancer patients treated with CyberKnife radi...MicroPhage Successfully Completes Beta Trial for Rapid MRSA Test
LONGMONT, Colo., Jan. 13 /PRNewswire/ -- A new bacterial identification test that rapidly identifies MRSA infections moved closer to market with conclusion of its first multicenter clinical trial, which was announced today by MicroPhage, Inc., http://www.microphage.com . The company also rep...Tasigna now shows potential to become the treatment of choice for certain newly diagnosed patients with chronic myeloid leukemia Two separate studies show rapid elimination of cancer cells in 96% of Tasigna patients and reduction of abnormal CML protein by six months ...
CIMZIA(R) Data Shows Long-term Improvements in Productivity, Quality of Life and Lessened Fatigue According to Studies Presented at American College of Rheumatology (ACR) Annual Scientific Meeting SAN FRANCISCO, Oct. 27 /PRNewswire/ -- 5:00 AM PST -- UCB announced today results from se...
Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
FirstVue(TM) HBSAG Test Found to Have Higher Sensitivity and Specificity than Other Rapid HBSAG Tests and FirstVue(TM) '...and was the preferred test in all phases of this evaluation' CORAL SPRINGS, Fla., Oct. 13 /PRNewswire/ -- AT First Diagnostic LLC an emerging worldwide m...$2 million in total funding expected by year's end NEW YORK, July 29 /PRNewswire-USNewswire/ -- Gene silencing techniques and induced pluripotent stem cell technology are among the cutting-edge approaches to Parkinson's drug development funded through The Michael J. Fox Foundation's Rapid Re...
SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM ) and its operating unit InnerCool Therapies announced today that positive findings from a preclinical study, demonstrating a new and expanded benefit of early rapid hyperthermia (cooling) for the potential treatmen...
ZFN Technology has Broad Applications in Research, Drug Development and Therapeutics ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL ) and Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the pub...
CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported data for IDX899, a non-nucleoside rever...
Marked Improvement in Four Regions of Body Consistent with Overall PASI Response in REMICADE-Treated Patients SAN ANTONIO, Feb. 4 /PRNewswire/ -- Data from an integrated analysis of three randomized, placebo-controlled trials showed patients with moderate to severe plaque psori...
- 85% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg and Pegasys(R) plus Copegus(R) with safety and tolerability comparable to placebo - - Conference Call Scheduled for 4:00PM ET Today - PRINCETON, N.J., Jan. 7 /PRNew...
Tests for Skin and Soft Tissue Infection and Blood Culture Extend European Product Line for Healthcare Acquired Infections SUNNYVALE, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the European release of Xpert(TM) MRSA/SA-Blood Cultures (BC) and Xper...
SAN FRANCISCO, Oct. 16 /PRNewswire/ -- Sugammadex -- the novel selective relaxant binding agent (SRBA) being developed by Organon -- demonstrated a faster recovery from profound neuromuscular blockade as compared to neostigmine in the Phase III pivotal Signal trial.(1) In a second trial, named...
Symptom resolution results based on stringent endpoint of clinical remission is more clinically relevant, beneficial to patients PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- An analysis of data to be presented tomorrow at the American College of Gastroenterology (ACG) Annual Scientif...
SUNNYVALE, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the termination of its contract with the Centers for Disease Control and Prevention (CDC) for development of a rapid point-of-care diagnostic to detect influenza viruses A and B, and the H5N1 "Avian In...
CHICAGO, Sept. 19 /PRNewswire/ -- Targanta Therapeutics Corporation today released detailed data from completed studies comparing the in vitro activity of its lead antibiotic drug candidate, oritavancin, to that of other antibiotics against a variety of susceptible and resistant strains of gra...
DALLAS, Sept. 12 /PRNewswire/ -- With equal access to medical care and medication, Hispanic men and women have as good or greater chance as non- Hispanics of controlling their high blood pressure. When researchers studied blood pressure control in Hispanics as part of the ALLHAT (Antihypertens...
First Molecular Test to Simultaneously Identify Staphylococcus Aureus and Methicillin-Resistant Staphylococcus Aureus from Nasal Specimens SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX ), announced today that it has ...
CLIA Waiver Submitted for Rapid HIV Test Employs StatSure's 'Barrel' Technology
FRAMINGHAM, Mass., Aug. 14 /PRNewswire-FirstCall/ -- StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR - News) is pleased to announce that its patented, "barrel- test" format for the detection of antibodies to HIV-1/2 in human whole blood, serum, and plasma has completed the trials n...Avian (Bird) Flu: Is There a Role for Rapid Tests?
Michael S. Singer, M.D., Ph.D. Corresponding Editor Harvard Medical School With human infections of bird flu (avian influenza) reported in Asia and Eastern Europe, public health officials have moved swiftly to develop policies on surveillance, diagnosis, and treatment. The virus in ques...Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
Helen Londe, M.D. Contributing Editor Clinical guidelines from the disciplines of cardiology and laboratory and emergency medicine have all emphasized the importance of cardiac markers in diagnosing or ruling out acute myocardial infarction. The measurement of cardiac troponins is especially usef...... O'Dea, MD, Chief Medical Officer of Radius. "The greater and faster accrual of BMD with BA058 may allow for shorter durations of treatment and a more rapid reduction in fracture risk in the severe osteoporotic postmenopausal population, which would be a significant advance in the treatment of this debilit...
... non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP((R)), which enables the rapid and efficient discovery of small molecule drug candidates. TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trade...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
...hat ZFN technology bypasses the current need to conduct cumbersome experiments involving nuclear transfer (cloning) or embryonic stem cells and allows rapid creation of new animal models." In the study published in Science titled "Knockout Rats via Embryo Microinjection of Zinc Finger Nucleases,......reast cancer," says Dr. O'Shaughnessy. "We expect that accrual will be very rapid within the US Oncology network and hope that this trial will lead to rapid FDA approval of what appears so far to be a well tolerated and effective th...
...linical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer. The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and BENLYSTA(TM) (belimumab, formerl...
...day announced that Dr. Alan Epstein of the USC Keck School of Medicine has received approval for a $3.5 million drug development project through the rapid Access to Intervention Development (RAID) program of the National Cancer Institute (NCI) for his breakthrough Interleukin-2 (IL-2) cytokine immunother...
Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
...ne Asacol HD 800 mg tablet has not been shown to be bioequivalent to two Asacol 400 mg tablets. In addition, Asacol HD at 4.8 g/day demonstrated rapid improvement in rectal bleeding and stool frequency. At three weeks, rectal bleeding improved in 78 percent and 75 percent of the patients in the ASCE......cience Center at Fort Worth have determined that rapid estrogen administration can protect the brain foll... these animal studies of the protective effects of rapid estrogen treatment to human patients with severe t.... "Our animal research has demonstrated that rapid estrogen intervention protects the brain following...
...ting properties of this novel long-acting anticoagulant." Svein Mathisen, CEO of BioInvent, also commented, "We are pleased that there has been rapid progress in this study and that the efficacy and safety monitoring board unanimously recommended that we proceed to a higher dose of TB-402. It is tes...
Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
...es by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment. Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple......ulting from eastbound travel. Jet lag disorder is an acute condition that occurs when a person's internal body clock becomes disrupted as a result of rapid travel across several time zones. Based on U.S. Bureau of Labor Statistics findings, an estimated 70 million American travelers experience jet lag an...
... Phil., Sangamo's vice president of research. "Moreover, the efficiency of this approach obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ability to quickly and selectively knock out multiple genes in the...
...arbazepine Acetate Eslicarbazepine acetate (ESL) is a novel once-daily voltage-gated sodium channel blocker designed to selectively inhibit the rapid firing of nerve cells that causes seizures. It specifically targets the inactivated state of the ion channel, preventing its return to the active stat...
Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
...tment of chronic obstructive pulmonary disease (COPD). NVA237 is a dry powder formulation for oral inhalation of glycopyrronium bromide, a LAMA with a rapid onset of activity. The study has now appeared on clinicaltrials.gov and will be recruiting in the next few weeks when the first patient first visit wi......monitoring. Through innovative wireless sensor technologies that use smartphones and broadband communication, we have the new capability of early and rapid detection of key parameters with a simple disposable smart 'band aid' that can relay the data on a continuous basis through the Internet." Parti...
...es company that commercializes breakthrough technologies for the molecular, rapid diagnostic testing market. The company is dedicated to development of simpl...improve automation, throughput, scalability, reliability and ease of use of rapid diagnostic testing for point-of-care settings such as physician's office la...
Other TagsOther Contents
(Date:6/19/2013)... is the most potent physiological anabolic agent for ... synthesis of lipids, protein and carbohydrates, and inhibiting ... It also plays a major role in stimulating ... is metabolized and removed from the blood following ... molecular mechanisms by which insulin regulates glucose uptake ...
(Date:6/19/2013)... form into the most perfectly spherical large objects in ... in a new study. It appears in ACS, journal ... Langmuir. , Julyan Cartwright, Antonio G. Checa and Marthe ... prized pearls have perhaps the most perfectly spherical, or ... are visible without a microscope. Pearls develop as nacre ...
(Date:6/19/2013)... ITHACA, N.Y. A Cornell University study offers further ... 4 million to 6 million years ago was profoundly ... in turning genes on and off. , The study, ... evidence for a 40-year-old hypothesis that regulation of genes ... is little difference between humans and chimps in the ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3(Date:6/19/2013)... percent of Americans are on at least one ... Mayo Clinic researchers say. Antibiotics, antidepressants and painkilling ... Twenty percent of patients are on five or ... online in the journal Mayo Clinic Proceedings ... of Dr. Jennifer St. Sauver talking about the ...
(Date:6/19/2013)... June 19, 2013 North Carolina-based ... organizational changes to advance development of its technologies. ... “To support the advanced development of our product ... to the Company’s management structure and engaged industry ... Company announced that Michael Galiger will serve as ...
(Date:6/19/2013)... Ga (PRWEB) June 19, 2013 Brightree ... and business management software solutions for the post-acute care industry, ... 79 - on the Healthcare Informatics 100 (HCI 100) ... IT companies in the U.S. in terms of revenue during ... at an average rate of 85% annually, and the company ...
(Date:6/19/2013)... Many trying-to-conceive couples seek medical intervention ... to a recent study published in ... of this research confirm what Fairhaven Health has ... that trying-to-conceive women would benefit from tracking ovulation, ... Fairhaven Health is a leading provider of ovulation ...
(Date:6/19/2013)... to the brink of extinction but can we finish ... which a Bristol academic addresses in his new book, published ... the University of Bristol, has produced the first comprehensive history ... story of polio explores the experiences of victims alongside the ... , According to a review by The ...
Breaking Medicine News(10 mins):Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Paralysed with fear: The story of polio 2[0] Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds[0] Entegrion Announces Organizational Changes to Support Advanced Product Development[0] Brightree Debuts on List of Top 100 Healthcare Technology Companies[0] Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies[0] Paralysed with fear: The story of polio
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |